Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.760
+0.230 (5.08%)
At close: Jun 26, 2026, 4:00 PM EDT
4.750
-0.010 (-0.21%)
Pre-market: Jun 29, 2026, 6:12 AM EDT
Immuneering Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Immuneering stock have an average target of 17, with a low estimate of 11 and a high estimate of 30. The average target predicts an increase of 257.14% from the current stock price of 4.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immuneering stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +152.10% | Jun 16, 2026 |
| Needham | Needham | Buy Maintains $11 | Buy | Maintains | $11 | +131.09% | Jun 2, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +320.17% | May 19, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 | Buy | Maintains | $12 | +152.10% | Apr 21, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $30 | Buy | Reiterates | $30 | +530.25% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
16.00M
EPS This Year
-1.14
from -1.27
EPS Next Year
-1.34
from -1.14
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 96.0M | |
| Avg | n/a | 16.0M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 1,193.8% |
| Avg | - | 158.8% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.95 | -0.62 | |
| Avg | -1.14 | -1.34 | |
| Low | -1.30 | -1.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.